PBYI
PUMA BIOTECHNOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$10.69
+4.60%Forward multiples
Based on analyst estimates
- P/E forward
- 46.48x
- P/E 2026E
- 28.21x
- P/E 2027E
- 53.60x
- P/E 2028E
- 71.47x
- P/S forward
- 8.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- 19.94x
- PEG TTM
- 0.09x
- Price / book
- 3.98x
- Price / sales
- 2.39x
- Price / cash flow
- 13.41x
Enterprise value
- Enterprise value
- $462.7M
- EV / sales
- 2.00x
- EV / EBITDA
- 10.25x
- EV / EBIT
- 15.20x
- Market cap
- $551.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026